Hypertension remains the leading cause of cardiovascular morbidity
and mortality in spite of current medical therapies. It has been
estimated that 50% of Western civilization has hypertension and
approximately 20% of patients have resistant hypertension. Renal
denervation (RDN) is a minimally invasive, endovascular catheter
based procedure using radiofrequency ablation aimed at treating
resistant hypertension. Early studies show a high degree of
effectiveness in renal denervation to treat hypertension. This book
examines renal pathophysiology and the rationale for renal
denervation, as well as possible long term benefits and risks of
this new therapy. The myriad of devices involved in the evolution
of this therapy are discussed and the book concludes with analyses
of the cost effectiveness and future applications.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!